Preeclampsia = high blood pressure (hypertension) during pregnancy
click here for details
- Preeclampsia 3X more likely if low vitamin D in mid-pregnancy - May 2023
- Preeclampsia 4 X more-likely if poor Vitamin D Receptor - Aug 2023
- Preeclampsia 1.5 more-likely if poor Vitamin D Receptor - meta-analysis April 2023
- Could Vitamin D Be Effective in Prevention of Preeclampsia? - Oct 2021
- 55+ VitaminDWiki pages with PREECLAMPSIA in title
- USPSTF want to screen all pregnacies for hypertension - Feb 2023 (far better to just give Vitamin D)
- VutaminDWiki - Hypertension category contains
- VitaminDWiki - Pregnancy category contains
- VitaminDWiki - Healthy pregnancies need lots of vitamin D contains
- There have been
7252 visits to this page
Association of maternal vitamin D status with the risk of preeclampsia
Food Funct. 2023 May 22;14(10):4859-4865. doi: 10.1039/d3fo00007a PDF is behind a paywall
Juhi Nema 1, Nisha Wadhwani 1, Karuna Randhir 1, Kamini Dangat 1, Hemlata Pisal 1, Vrushali Kadam 1, Savita Mehendale 2, Girija Wagh 2, Bharati Kulkarni 3, Harshpal Singh Sachdev 4, Caroline Fall 5, Sanjay Gupte 6, Sadhana Joshi 1
The aim of this study was to examine serum vitamin D concentrations from early pregnancy until delivery in women who did and did not develop preeclampsia. This longitudinal study was carried out in Pune, India. A total of 1154 women with singleton pregnancies were recruited in early pregnancy from two hospitals. Blood samples were collected and stored at four time points across gestation: V1 = 11-14 weeks, V2 = 18-22 weeks, V3 = 26-28 weeks and V4 = at delivery. 108 women who developed preeclampsia (PE) and 216 who did not develop PE (Non-PE) were randomly selected from the remainder. Serum 25-hydroxy vitamin D concentrations (25(OH)D) were estimated in their samples using commercially available ELISA kits. Independent t-tests were used to compare 25(OH)D between PE and non-PE groups. Logistic and linear regressions were used to examine associations of 25(OH)D with the risk of preeclampsia and birth outcomes, respectively, after adjusting for confounders. The mean (SD) 25(OH)D at V1 was 21.95 (19.64) in the Non-PE group and 17.76 (13.21) in the PE group.
A decrease in the concentrations of vitamin D (ng ml-1) in mid-pregnancy (V2) and at delivery was associated with an increased risk of preeclampsia (0.31 [95% CI 0.11, 0.86], p = 0.024 and 0.24 [95% CI 0.08, 0.77], p = 0.016), respectively. Our finding of lower vitamin D concentrations in mid-pregnancy, before women developed clinical preeclampsia, suggests that vitamin D may have a role in its pathophysiology.
Impact of vitamin D binding protein (GC) and vitamin D receptor (VDR) gene polymorphism on the risk of developing preeclampsia
Biochemistry and Biophysics Reports Vol 35, Sept 2023, 101526 https://doi.org/10.1016/j.bbrep.2023.101526
Md Mostafijur Rahman a 1, Tamima Nawfal a 1, Fabliha Afiea Khabir a 1, Md Bayejid Hosen a, Mubasshir Washif a, Yearul Kabir b, M Zakir Hossain Howlader a
Preeclampsia is a multifactorial disease characterized by high blood pressure and protein in the urine. In this study, we investigated the association of vitamin D binding protein (GC) and vitamin D receptor (VDR) gene polymorphism with the risk of developing preeclampsia.
25-hydroxyvitamin D was measured using High-performance Liquid Chromatography. Vitamin D binding protein and vitamin D receptor gene polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism.
The control subjects have significant higher level of 25-hydroxyvitamin D (33.5 ± 1.194 ng/mL) relative to patients (23.97 ± 1.604 ng/mL) (p < 0.05). Vitamin D receptor rs1544410 and rs2228570 dominant model (GA + AA; TC + CC) showed significant higher risk of developing Preeclampsia (OR = 4.11, 95% CI = 0.62–27.09, p < 0.01; OR = 3.58, 95%CI = 0.78–16.38, p < 0.001 respectively). Similarly, vitamin D binding protein rs7041 and rs4588, dominant model (TG + GG; CA + AA) showed higher risk of preeclampsia development compared to control people (OR = 1.69, 95%CI = 0.35–8.19, p < 0.05; OR = 1.06, 95%CI = 0.25–4.44, p < 0.05 respectively). AA genotype of rs4588 of GC gene was significantly associated with 25-hydroxyvitamin D level in serum relative to CC and CA (p < 0.05).
From our study, we can conclude that a low level of 25-hydroxyvitamin D, GC (rs1544410 and rs2228570), and VDR (rs4588 and rs7041) gene polymorphism is linked with an increased risk of developing preeclampsia.
Download the PDF from VitaminDWiki
Association between Vitamin D receptor (VDR) gene polymorphisms and hypertensive disorders of pregnancy: a systematic review and meta-analysis
PeerJ. 2023 Apr 25;11:e15181. doi: 10.7717/peerj.15181
Yicong Guo # 1, Yu Zhang # 2, Xiangling Tang 2, Xionghao Liu 2, Huilan Xu 1
Background: Hypertensive disorders of pregnancy (HDP) are currently one of the major causes of pregnancy-related maternal and fetal morbidity and mortality worldwide. Recent studies provide evidence that maternal Vitamin D receptor (VDR) gene polymorphisms probably play a key role by affecting the biological function of vitamin D in some adverse pregnancy outcomes, while the relationship between the VDR gene polymorphisms and the risk of HDP remains controversial in current studies. This systematic review and meta-analysis aimed to comprehensively evaluate the association of the VDR gene polymorphisms with HDP susceptibility.
Methods: This meta-analysis follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and a protocol has been registered in the PROSPERO (ID: CRD42022344383) before commencing this review. PubMed, Web of Science, Embase, and the Cochrane Library databases were searched until January 21, 2023. Case-control and cohort studies that reported the association of the VDR gene polymorphisms with HDP were included. The quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS) for non-randomized studies. The odds ratios (ORs) with corresponding 95% confidence intervals (CIs) of the five models (allele model, dominant model, recessive model, homozygous model, heterozygous model) were pooled respectively, and subgroup analysis was performed based on ethnicity.
Results: A total of ten studies were included. The VDR gene ApaI polymorphism was associated with HDP susceptibility in the dominant model (OR: 1.38; 95% CI [1.07-1.79]; P = 0.014) and the heterozygote model (OR: 1.48; 95% CI [1.12-1.95]; P = 0.006). In subgroup analysis, the heterozygote model (OR: 2.06; 95% CI [1.21-3.52]; P = 0.008) of the ApaI polymorphism was associated with HDP in Asians, but not in Caucasians.
Conclusion: The VDR gene ApaI polymorphism may be associated with HDP susceptibility. Insufficient evidence to support the existence of ethnic differences in this association.
Download the PDF from VitaminDWiki
Nutrients 2021, 13(11), 3854; https://doi.org/10.3390/nu13113854
by Elżbieta Poniedziałek-Czajkowska *ORCID andRadzisław MierzyńskiORCID
Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, 20-954 Lublin, Poland
(This article belongs to the Special Issue Role of Vitamin D Deficiency in Pregnancy Disorders)
Prevention of preeclampsia (PE) remains one of the most significant problems in perinatal medicine. Due to the possible unpredictable course of hypertension in pregnancy, primarily PE and the high complication rate for the mother and fetus/newborn, it is urgent to offer pregnant women in high-risk groups effective methods of preventing the PE development or delaying its appearance. In addition, due to the association of PE with an increased risk of developing cardiovascular diseases (CVD) in later life, effective preeclampsia prevention could also be important in reducing their incidence. Ideal PE prophylaxis should target the pathogenetic changes leading to the development of PE and be safe for the mother and fetus, inexpensive and freely available. Currently, the only recognized method of PE prevention recommended by many institutions around the world is the use of a small dose of acetylsalicylic acid in pregnant women with risk factors. Unfortunately, some cases of PE are diagnosed in women without recognized risk factors and in those in whom prophylaxis with acetylsalicylic acid is not adequate. Hence, new drugs which would target pathogenetic elements in the development of preeclampsia are studied. Vitamin D (Vit D) seems to be a promising agent due to its beneficial effect on placental implantation, the immune system, and angiogenic factors. Studies published so far emphasize the relationship of its deficiency with the development of PE, but the data on the benefits of its supplementation to reduce the risk of PE are inconclusive. In the light of current research, the key issue is determining the protective concentration of Vit D in a pregnant woman. The study aims to present the possibility of using Vit D to prevent PE, emphasizing its impact on the pathogenetic elements of preeclampsia development.
more columns are in the PDF
Currently, the commonly recommended preeclampsia prophylaxis is the use of low doses of acetylsalicylic acid in high-risk pregnant women and, by some institutions, calcium supplementation in groups with its deficiencies in the diet. Numerous studies are being conducted on the use of other substances and drugs for this purpose, which, due to their properties and mechanisms of action, could prevent the development of preeclampsia. One of these thoroughly studied substances is vitamin D. Based on the results of research explaining its mechanism of action and understanding the reasons and pathophysiology of the development of preeclampsia, it might be postulated that an anti-inflammatory effect of Vit D and its beneficial influence on the endothelium constitutes its potential use in PE prevention. Unfortunately, the results of the randomized controlled trials and meta-analyses are ambiguous. Despite the multitude of studies published on this subject, there are no clear conclusions about its effectiveness in PE prevention which could form the basis for developing universal recommendations.
In the light of the available data, the following issues regarding the role of vitamin D in preventing preedampsia remain unresolved:
- 1. Should the target group for vitamin D supplementation be all pregnant women or only those at high risk?
- 2. Should it be recommended to test the vitamin D concentration in the periconceptional period and the early first trimester in all pregnant women or a high-risk group?
- 3. Since when (during the planning period of pregnancy or in the first trimester),
- how long and what doses of vitamin D should be proposed considering the safety of offspring?
- 4. What vitamin D level in the periconceptional period and the first trimester should be considered sufficient?
These questions may determine the direction of research on vitamin D in the prevention of preeclampsia.
It seems that the fundamental issue, despite the extensive literature, remains the assessment of Vit D concentration in the periconceptional period and/or the early first trimester and defining levels that would allow reducing the risk of PE development. Women with risk factors for Vit D deficiency such as obesity, kidney, liver, thyroid gland diseases, chronic bowel diseases, autoimmune diseases, asthma, diabetes t.2, hypertension, and chronic glucocorticoids, antiepileptic and antiretroviral drug treatment would benefit the most from screening. It appears that patients with risk factors for PE development and Vit D deficiency may require higher doses of vitamin D than commonly recommended for pregnant women.
Download the PDF from VitaminDWiki
This list is automatically updatedItems found: 57
USPSTF want to screen all pregnacies for hypertension - Feb 2023 (far better to just give Vitamin D)
USPSTF backs screening for hypertensive disorders of pregnancy MDEdge
U.S. Preventive Services Task Force = USPSTF
16% of US pregnancies had hypertension in 2019
VutaminDWiki - Hypertension category contains
161 items in the category HYPERTENSION
Overview Overview Hypertension and Vitamin D
Overview Cardiovascular and vitamin D
Overview Stroke and vitamin D
Incidence of 22 health problems related to vitamin D have doubled in a decade
Some interesting Hypertension studies
- Hypertension risk decreased 10X by increasing vitamin D levels to more than 40 ng – Nov 2017
- COVID-19 deaths 4 to 7 X more likely if Diabetic, Hypertensive, or CVD - meta-analysis March 2020
- Drug-resistant hypertension 3.5 X more likely if low vitamin D – March 2020
- High Blood Pressure reduced by Vitamin D supplementation in seniors and obese – meta-analysis May 2019
- Blood pressure in diabetics reduced by 12 weekly doses of 50,000 IU vitamin D – RCT Jan 2014
- Hypertension is associated with low vitamin D in some groups – meta-analysis April 2015
- Off Topic – Hypertension in 42 percent of adults (new definition: 130 mm Hg) – Feb 2018
- Men aged 40-59 59%, age >60 75%: National Health and Nutrition Examination Survey, 2017–2018
VitaminDWiki - Pregnancy category contains
859 items in Pregnancy category
- see also
- Overview Pregnancy and vitamin D
- Number of articles in both categories of Pregnancy and:Dark Skin
27 ; Depression 21 ; Diabetes 43 ; Obesity 15 ; Hypertension 43 ; Breathing 33 ; Omega-3 39 ; Vitamin D Receptor 24 Click here for details
- All items in category Infant/Child
- Pregnancy needs at least 40 ng of vitamin D, achieved by at least 4,000 IU – Hollis Aug 2017
- 38+ papers with Breastfed etc, in the title
- Call to action – more Vitamin D for pregnancies, loading doses are OK – Holick Aug 2019
- 53+ preeclampsia studies
- 94+ studies with PRETERM in the title
- "polycystic ovary syndrome" OR PCOS 303 items as of Jan 2018
- 94+ Gestational Diabetes
- c-section OR "caesarean section" (various spellings) 937 items in text as of Aug 2020
- postpartum depression 208 items as of Aug 2018
- 31 VitaminDWiki pages had MISCARRIAGE in title as of Aug 2022
- Search VitaminDWiki for "Assisted reproduction" 33 items as of Aug 2022
- Fertility and Sperm category listing has
131 items along with related searches
- (Stunting OR “low birth weight” OR LBW) 1180 items as of June 2020
- Less labor pain if higher level of vitamin D – August 2021
- Healthy pregnancies need lots of vitamin D
- Ensure a healthy pregnancy and baby - take Vitamin D before conception
VitaminDWiki - Healthy pregnancies need lots of vitamin D containsProblem
Reduces Evidence 0. Chance of not conceiving 3.4 times Observe 1. Miscarriage 2.5 times Observe 2. Pre-eclampsia 3.6 times RCT 3. Gestational Diabetes 3 times RCT 4. Good 2nd trimester sleep quality 3.5 times Observe 5. Premature birth 2 times RCT 6. C-section - unplanned 1.6 times Observe Stillbirth - OMEGA-3 4 times RCT - Omega-3 7. Depression AFTER pregnancy 1.4 times RCT 8. Small for Gestational Age 1.6 times meta-analysis 9. Infant height, weight, head size
within normal limits
RCT 10. Childhood Wheezing 1.3 times RCT 11. Additional child is Autistic 4 times Intervention 12.Young adult Multiple Sclerosis 1.9 times Observe 13. Preeclampsia in young adult 3.5 times RCT 14. Good motor skills @ age 3 1.4 times Observe 15. Childhood Mite allergy 5 times RCT 16. Childhood Respiratory Tract visits 2.5 times RCT
RCT = Randomized Controlled Trial
There have been
7252 visits to this pageThis page is in the following categories (# of items in each category)
ID Name Comment Uploaded Size Downloads 19916 Preclampsia table.jpg admin 07 Aug, 2023 00:27 161.03 Kb 31 19915 preeclampsia VDR.jpg admin 07 Aug, 2023 00:27 56.27 Kb 32 19914 preeclampsia VDR_CompressPdf.pdf PDF 2023 admin 07 Aug, 2023 00:26 362.74 Kb 25 19532 preeclampsia signs.jpg admin 01 May, 2023 16:06 33.95 Kb 156 19531 preeclampsia VDR meta_CompressPdf.pdf PDF 2023 admin 01 May, 2023 15:48 294.87 Kb 64 16509 PE meta.jpg admin 28 Oct, 2021 15:26 215.67 Kb 244 16508 PE RCT.jpg admin 28 Oct, 2021 15:25 106.66 Kb 238 16507 Preeclampsia 2021.pdf PDF 2021 admin 28 Oct, 2021 14:27 989.80 Kb 221
- All items in category Infant/Child
- There have been